Morphochem announces determination of the X-ray structure of Endothelin Converting Enzyme (ECE-1) complexed with Phosphoramidon
Morphochem applied its protein expression, purification, crystallization and structure determination capabilities to generate biostructural information for further optimization of inhibitor compounds against Endothelin-Converting Enzyme.
Commenting on the collaboration, Glenn E. Dale, Head of Biological Sciences at Morphochem said: "We are delighted that Morphochem could rapidly and successfully determine the three-dimensional structure of ECE-1 complexed with phosphoramidon, thereby providing the necessary tools to Solvay for this very important target."
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.